CRISPR Therapeutics to Present at the American Society of Ge

ZUG, Switzerland and BOSTON, April 01, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting, taking place May 7 – 11, 2024, in Baltimore, MD and virtually. Title: Development of an In Vivo Non-Viral Ocular Editing Platform and Application to Potential Treatments for Glaucom

Related Keywords

California , United States , Boston , Massachusetts , United Kingdom , Switzerland , London , City Of , San Francisco , Susan Kim , American Society Of Gene Cell Therapy , Vertex Pharmaceuticals , Therapeutics Inc , Nasdaq , American Society , Cell Therapy , Vivo Non Viral Ocular Editing Platform , Potential Treatments , In Person Oral Presentation , Wednesday May , Nobel Prize Winning , Crispr Therapeutics , Oral Presentation , Iopharmaceutical Company , Zug , Gene Editing ,